Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), most commonly known as Crohn’s disease (CD) and ulcerative disease (UC), is a chronic and relapsing intestinal disease which cannot be cured completely. The prevalence of IBD in Europe and in North America has increased over the past 20 years. As most IBD patients a...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2020/7397523 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832553275156594688 |
|---|---|
| author | Qiyue Wang Shuyi Mi Zixuan Yu Qiyi Li Jiacai Lei |
| author_facet | Qiyue Wang Shuyi Mi Zixuan Yu Qiyi Li Jiacai Lei |
| author_sort | Qiyue Wang |
| collection | DOAJ |
| description | Inflammatory bowel disease (IBD), most commonly known as Crohn’s disease (CD) and ulcerative disease (UC), is a chronic and relapsing intestinal disease which cannot be cured completely. The prevalence of IBD in Europe and in North America has increased over the past 20 years. As most IBD patients are young at onset, their quality of life (QOL) can be influenced to varying degrees. Thus, current treatment goals are typically focused on preventing complications, including maintaining clinical remission and improving the QOL. Adjuvant therapies have been widely concerned as an effective treatment in alleviating IBD symptoms, including dietary intervention, traditional Chinese medicine, smoking, alcohol, and physical activities. This review focuses on different ancillary therapies for IBD treatments, in particular the mechanism of reducing inflammation based on the actual data from research studies. Moreover, comparing the latest data, this review also presented potential future prospect for adjuvant therapies. |
| format | Article |
| id | doaj-art-8c3f4451d67341ceb8f4a1eb8780b958 |
| institution | Kabale University |
| issn | 2291-2789 2291-2797 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology and Hepatology |
| spelling | doaj-art-8c3f4451d67341ceb8f4a1eb8780b9582025-02-03T05:54:25ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972020-01-01202010.1155/2020/73975237397523Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel DiseaseQiyue Wang0Shuyi Mi1Zixuan Yu2Qiyi Li3Jiacai Lei4Department of Gastroenterology, Hangzhou Da Jiangdong Hospital, Hangzhou, Zhejiang Province, ChinaSchool of Medicine, Zhejiang University City College, Hangzhou, Zhejiang Province, ChinaSchool of Medicine, Zhejiang University City College, Hangzhou, Zhejiang Province, ChinaSchool of Medicine, Zhejiang University City College, Hangzhou, Zhejiang Province, ChinaDepartment of Gastroenterology, Hangzhou Da Jiangdong Hospital, Hangzhou, Zhejiang Province, ChinaInflammatory bowel disease (IBD), most commonly known as Crohn’s disease (CD) and ulcerative disease (UC), is a chronic and relapsing intestinal disease which cannot be cured completely. The prevalence of IBD in Europe and in North America has increased over the past 20 years. As most IBD patients are young at onset, their quality of life (QOL) can be influenced to varying degrees. Thus, current treatment goals are typically focused on preventing complications, including maintaining clinical remission and improving the QOL. Adjuvant therapies have been widely concerned as an effective treatment in alleviating IBD symptoms, including dietary intervention, traditional Chinese medicine, smoking, alcohol, and physical activities. This review focuses on different ancillary therapies for IBD treatments, in particular the mechanism of reducing inflammation based on the actual data from research studies. Moreover, comparing the latest data, this review also presented potential future prospect for adjuvant therapies.http://dx.doi.org/10.1155/2020/7397523 |
| spellingShingle | Qiyue Wang Shuyi Mi Zixuan Yu Qiyi Li Jiacai Lei Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease Canadian Journal of Gastroenterology and Hepatology |
| title | Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease |
| title_full | Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease |
| title_fullStr | Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease |
| title_full_unstemmed | Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease |
| title_short | Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease |
| title_sort | opening a window on attention adjuvant therapies for inflammatory bowel disease |
| url | http://dx.doi.org/10.1155/2020/7397523 |
| work_keys_str_mv | AT qiyuewang openingawindowonattentionadjuvanttherapiesforinflammatoryboweldisease AT shuyimi openingawindowonattentionadjuvanttherapiesforinflammatoryboweldisease AT zixuanyu openingawindowonattentionadjuvanttherapiesforinflammatoryboweldisease AT qiyili openingawindowonattentionadjuvanttherapiesforinflammatoryboweldisease AT jiacailei openingawindowonattentionadjuvanttherapiesforinflammatoryboweldisease |